BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22896003)

  • 1. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
    Allen JL; Fore MS; Wooten J; Roehrs PA; Bhuiya NS; Hoffert T; Sharf A; Deal AM; Armistead P; Coghill J; Gabriel DA; Irons R; Essenmacher A; Shea TC; Richards K; Cutler C; Ritz J; Serody J; Baldwin AS; Sarantopoulos S
    Blood; 2012 Sep; 120(12):2529-36. PubMed ID: 22896003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
    Jacobson CA; Sun L; Kim HT; McDonough SM; Reynolds CG; Schowalter M; Koreth J; Cutler CS; Ho VT; Alyea EP; Armand P; Blazar BR; Soiffer RJ; Antin JH; Ritz J; Sarantopoulos S
    Biol Blood Marrow Transplant; 2014 May; 20(5):668-75. PubMed ID: 24462743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Cutler CS; Bhuiya NS; Schowalter M; Ho VT; Alyea EP; Koreth J; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2009 Apr; 113(16):3865-74. PubMed ID: 19168788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
    Jia W; Poe JC; Su H; Anand S; Matsushima GK; Rathmell JC; Maillard I; Radojcic V; Imai K; Reyes NJ; Cardona DM; Li Z; Suthers AN; Curry-Chisolm IM; DiCioccio RA; Saban DR; Chen BJ; Chao NJ; Sarantopoulos S
    Blood; 2021 May; 137(18):2544-2557. PubMed ID: 33534893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
    Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
    Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Washel WS; Bhuiya NS; Cutler CS; Alyea EP; Ho VT; Soiffer RJ; Antin JH; Ritz J
    Blood; 2011 Feb; 117(7):2275-83. PubMed ID: 21097674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased BCR responsiveness in B cells from patients with chronic GVHD.
    Allen JL; Tata PV; Fore MS; Wooten J; Rudra S; Deal AM; Sharf A; Hoffert T; Roehrs PA; Shea TC; Serody JS; Richards KL; Jagasia M; Lee SJ; Rizzieri D; Horwitz ME; Chao NJ; Sarantopoulos S
    Blood; 2014 Mar; 123(13):2108-15. PubMed ID: 24532806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells in chronic graft-versus-host disease.
    McManigle W; Youssef A; Sarantopoulos S
    Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells in chronic graft-versus-host disease.
    Sarantopoulos S; Blazar BR; Cutler C; Ritz J
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):16-23. PubMed ID: 25452031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
    Front Immunol; 2020; 11():1505. PubMed ID: 32849514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Bhuiya NS; Cutler CS; Soiffer RJ; Antin JH; Ritz J
    Clin Cancer Res; 2007 Oct; 13(20):6107-14. PubMed ID: 17947475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.
    Hillhouse EE; Thiant S; Moutuou MM; Lombard-Vadnais F; Parat R; Delisle JS; Ahmad I; Roy DC; Guimond M; Roy J; Lesage S
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):19-25. PubMed ID: 30244108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
    Poe JC; Jia W; Su H; Anand S; Rose JJ; Tata PV; Suthers AN; Jones CD; Kuan PF; Vincent BG; Serody JS; Horwitz ME; Ho VT; Pavletic SZ; Hakim FT; Owzar K; Zhang D; Blazar BR; Siebel CW; Chao NJ; Maillard I; Sarantopoulos S
    Blood; 2017 Nov; 130(19):2131-2145. PubMed ID: 28851699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing role of B cells in the pathogenesis and treatment of chronic GVHD.
    Li X; Gao Q; Feng Y; Zhang X
    Br J Haematol; 2019 Feb; 184(3):323-336. PubMed ID: 30585319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
    Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
    Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication.
    Glauzy S; Soret J; Fournier I; Douay C; Moins-Teisserenc H; Peffault de Latour R; Maki G; Robin M; Socié G; Toubert A; Clave E
    Blood; 2014 Oct; 124(15):2459-62. PubMed ID: 25185266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.
    Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Snavely J; Chen H; Savani BN; Kassim A; Greer JP; Schuening FG; Engelhardt BG; Jagasia MH
    Blood; 2011 Jul; 118(4):1140-4. PubMed ID: 21628416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant B-cell homeostasis in chronic GVHD.
    Sarantopoulos S; Ritz J
    Blood; 2015 Mar; 125(11):1703-7. PubMed ID: 25645355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
    Rozmus J; Kariminia A; Abdossamadi S; Storer BE; Martin PJ; Lee SJ; Wolff D; Arora M; Cutler C; Schultz KR
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):451-458. PubMed ID: 30447393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.